Drugs / Tripotassium dicitrate BM
last change 13 days ago re-read 9 days ago

Tripotassium dicitrate BM

Developed for
Helicobacter pylori infectious disease

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT07855497 Comparator Feb 2021 → Sep 2026 overdue Helicobacter pylori infectious disease Seoul National University Bundang Hospital Active not recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tripotassium dicitrate BM “tripotassium dicitrate BM 300 mg four times daily” NCT07855497 ↗